LDN Social Media
Get connected with us on social networks
AgelessRx Initiates Study on LDN and NAD+ as a Treatment for Long COVID Sufferers
PRESS RELEASE
Published March 27, 2024
Digital Journal
Ann Arbor, MI - AgelessRx, a pioneering leader in longevity research and personalized medicine, has embarked on a study aimed at exploring the efficacy of Low Dose Naltrexone (LDN) and Nicotinamide Adenine Dinucleotide (NAD+) as potential treatments for individuals experiencing symptoms of Long COVID.
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a significant health concern affecting millions of individuals worldwide. Despite the widespread distribution of vaccines, many individuals continue to experience debilitating symptoms long after their initial COVID-19 infection has resolved.
Recognizing the urgent need for effective treatment options for Long COVID sufferers, AgelessRx has initiated a comprehensive research study to investigate the therapeutic potential of LDN and NAD+. LDN, traditionally used to treat autoimmune conditions and chronic pain, has shown promise in modulating the immune response, while NAD+ has been linked to various cellular processes, including energy metabolism and DNA repair.
The study, which marks a significant stride in the search for an effective Long COVID treatment, revealed that 52% of participants experienced considerable improvements in energy, pain, and physical health, leading to a 20% enhancement in overall quality of life. These promising results underscore the potential of LDN and NAD+ therapy not just in alleviating fatigue but in substantially improving the quality of life for Long COVID sufferers, suggesting a hopeful avenue for future treatment protocols.
This study reflects AgelessRx's commitment to exploring and validating cutting-edge treatments that could significantly impact public health, especially for those dealing with the long-term impacts of the COVID pandemic.
AgelessRx invites readers to explore this study and embark on a journey towards learning new ways to combat Long COVID. For more information about AgelessRx's groundbreaking study on LDN and NAD+ for Long COVID, please visit the blog post at https://agelessrx.com/ldn-nad-offer-hope-for-long-covid/.